Sir, – I welcome Dr Houston’s article on PSA and prostate cancer (“We have a blood test to detect prostate cancer, so why the reluctance to screen?”, Your Wellness, February 23rd). After more than 40 ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

PSA's February 2026 Price Hike Details PSA implemented these psa grading price increases in February 2026 to match surging demand with operational capacity, ensuring more reliable service delivery.

The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over ...

We came across a bullish thesis on Public Storage on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on PSA. Public Storage’s share was trading at $304.11 as of ...

Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding ...

Hormonal therapy only benefitted men receiving postoperative radiotherapy who had a PSA greater than 0.5 ng/mL at the time of radiation.

A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage trial investigated a form of radiotherapy on patients who had stopped ...

When Team USA won gold medals in men's and women's hockey at the 2026 Winter Olympics in Milan-Cortina, the achievement ...

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...

Platform analyzes trading cards across 47 inspection points in under 60 seconds with 92.8% accuracy We started ...